Woo LW - Search Results

1

Steroid sulfatase: a new target for the endocrine therapy of breast cancer.

Stanway SJ, Delavault P, Purohit A, Woo LW, Thurieau C, Potter BV, Reed MJ. Stanway SJ, et al. Among authors: woo lw. Oncologist. 2007 Apr;12(4):370-4. doi: 10.1634/theoncologist.12-4-370. Oncologist. 2007. PMID: 17470679 Free article. Review.

2

Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2-methoxyoestradiol-bis-sulphamate.

Raobaikady B, Purohit A, Chander SK, Woo LW, Leese MP, Potter BV, Reed MJ. Raobaikady B, et al. Among authors: woo lw. J Steroid Biochem Mol Biol. 2003 Feb;84(2-3):351-8. doi: 10.1016/s0960-0760(03)00049-9. J Steroid Biochem Mol Biol. 2003. PMID: 12711022

3

The role of steroid sulphatase in regulating the oestrogenicity of oestrogen sulphamates.

Chander SK, Purohit A, Woo LW, Potter BV, Reed MJ. Chander SK, et al. Among authors: woo lw. Biochem Biophys Res Commun. 2004 Sep 10;322(1):217-22. doi: 10.1016/j.bbrc.2004.07.108. Biochem Biophys Res Commun. 2004. PMID: 15313194

4

Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor.

Stanway SJ, Purohit A, Woo LW, Sufi S, Vigushin D, Ward R, Wilson RH, Stanczyk FZ, Dobbs N, Kulinskaya E, Elliott M, Potter BV, Reed MJ, Coombes RC. Stanway SJ, et al. Among authors: woo lw. Clin Cancer Res. 2006 Mar 1;12(5):1585-92. doi: 10.1158/1078-0432.CCR-05-1996. Clin Cancer Res. 2006. PMID: 16533785 Free article. Clinical Trial.

5

Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer.

Foster PA, Chander SK, Parsons MF, Newman SP, Woo LW, Potter BV, Reed MJ, Purohit A. Foster PA, et al. Among authors: woo lw. Breast Cancer Res Treat. 2008 Sep;111(1):129-38. doi: 10.1007/s10549-007-9769-3. Epub 2007 Oct 4. Breast Cancer Res Treat. 2008. PMID: 17914670

6

The use of steroid sulfatase inhibitors as a novel therapeutic strategy against hormone-dependent endometrial cancer.

Foster PA, Woo LW, Potter BV, Reed MJ, Purohit A. Foster PA, et al. Among authors: woo lw. Endocrinology. 2008 Aug;149(8):4035-42. doi: 10.1210/en.2008-0223. Epub 2008 May 1. Endocrinology. 2008. PMID: 18450955 Free PMC article.

7

Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography.

Woo LW, Fischer DS, Sharland CM, Trusselle M, Foster PA, Chander SK, Di Fiore A, Supuran CT, De Simone G, Purohit A, Reed MJ, Potter BV. Woo LW, et al. Mol Cancer Ther. 2008 Aug;7(8):2435-44. doi: 10.1158/1535-7163.MCT-08-0195. Mol Cancer Ther. 2008. PMID: 18723489 Free article.

8

A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor.

Foster PA, Chander SK, Newman SP, Woo LW, Sutcliffe OB, Bubert C, Zhou D, Chen S, Potter BV, Reed MJ, Purohit A. Foster PA, et al. Among authors: woo lw. Clin Cancer Res. 2008 Oct 15;14(20):6469-77. doi: 10.1158/1078-0432.CCR-08-1027. Clin Cancer Res. 2008. PMID: 18927286 Free article.

9

The development of steroid sulfatase inhibitors for hormone-dependent cancer therapy.

Day JM, Purohit A, Tutill HJ, Foster PA, Woo LW, Potter BV, Reed MJ. Day JM, et al. Among authors: woo lw. Ann N Y Acad Sci. 2009 Feb;1155:80-7. doi: 10.1111/j.1749-6632.2008.03677.x. Ann N Y Acad Sci. 2009. PMID: 19250195 Review.

10

Development of steroid sulfatase inhibitors.

Woo LW, Purohit A, Potter BV. Woo LW, et al. Mol Cell Endocrinol. 2011 Jul 4;340(2):175-85. doi: 10.1016/j.mce.2010.12.035. Epub 2011 Jan 14. Mol Cell Endocrinol. 2011. PMID: 21238537 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62 results

Search Page